These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 5024896)

  • 21. [Adamantylamine sulfate--a drug for treatment of Parkinson's disease with a new working principle].
    Fünfgeld EW
    Med Klin; 1970 Sep; 65(39):1703-6. PubMed ID: 5474341
    [No Abstract]   [Full Text] [Related]  

  • 22. [Amantadine in the treatment of Parkinson's syndrome: studied in 31 patients for 3 months].
    Campanella G; Zallone E; Buscaino GA
    Acta Neurol (Napoli); 1972; 27(5):491-500. PubMed ID: 4564842
    [No Abstract]   [Full Text] [Related]  

  • 23. [Amantadine in Parkinson's disease].
    Streifler M; Kallay U
    Harefuah; 1972 Jun; 82(11):499-503. PubMed ID: 5068899
    [No Abstract]   [Full Text] [Related]  

  • 24. ["Nil nocere." Side effects during treatment of Parkinson's disease with amantadine].
    Diehl LW
    Munch Med Wochenschr; 1972 Mar; 114(10):445-7. PubMed ID: 4625982
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of Parkinson's disease with amantadine].
    Sigwald J; Raymondeaud C; Grégoire J
    Therapeutique; 1972 Nov; 48(9):555-60. PubMed ID: 4568230
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effects of additional medication of Amantadine sulfate in L-dopa-pretreated patients with Parkinson's syndrome (author's transl)].
    Schneider E; Fischer PA; Jacobi P
    Med Klin; 1974 Mar; 69(13):541-5. PubMed ID: 4831456
    [No Abstract]   [Full Text] [Related]  

  • 27. [Amandatine hydrochloride (Symmetrel) in the treatment of parkinsonism].
    Nikolić M; Lević Z
    Srp Arh Celok Lek; 1976 Feb; 104(2):113-8. PubMed ID: 1013802
    [No Abstract]   [Full Text] [Related]  

  • 28. Plasma amantadine concentrations in patients with Parkinson's disease.
    Nishikawa N; Nagai M; Moritoyo T; Yabe H; Nomoto M
    Parkinsonism Relat Disord; 2009 Jun; 15(5):351-3. PubMed ID: 18823813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The additive effect of amantadine hydrochloride (Symmetrel) on parkinsonian patients receiving levodopa treatment (author's transl)].
    Shiozawa R; Kase M; Kuroiwa Y; Narabayashi H; Nishitani Y; Ohmoto T; Toyokura Y; Uono K
    No To Shinkei; 1981 Mar; 33(3):301-9. PubMed ID: 7018522
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effects of amantadine therapy on sleep spindles in patients with parkinsonism and comparative analysis of L-dopa effects].
    Puca FM; Pigneri MT
    Boll Soc Ital Biol Sper; 1972 May; 48(9):237-40. PubMed ID: 5070096
    [No Abstract]   [Full Text] [Related]  

  • 31. [The effect of amantadine in parkinsonism: clinical and neurophysiological findings].
    Fünfgeld EW
    Dtsch Med Wochenschr; 1970 Sep; 95(36):1834-6. PubMed ID: 5453004
    [No Abstract]   [Full Text] [Related]  

  • 32. [Amantadine and dexetimide in the treatment of parkinsonism].
    Hakkarainen H; Viukari M
    Duodecim; 1973 Jul; 89(21):1437-41. PubMed ID: 4586970
    [No Abstract]   [Full Text] [Related]  

  • 33. Amantadine and other antiglutamate agents: management of Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S13-22. PubMed ID: 12211136
    [No Abstract]   [Full Text] [Related]  

  • 34. Fotosensitization by Amantadine (Symmetrel).
    van Ketel WG; Goedhart-van Dijk B
    Dermatologica; 1974; 148(2):124-6. PubMed ID: 4837658
    [No Abstract]   [Full Text] [Related]  

  • 35. Visual hallucinations and delirium during treatment with amantadine (Symmetrel).
    Postma JU; Van Tilburg W
    J Am Geriatr Soc; 1975 May; 23(5):212-5. PubMed ID: 123540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Amantadine therapy of Parkinson's syndrome. Comment on L.W. Diehl: "Nil nocere. Adverse effects of amantadine therapy of parkinsnism"].
    Völler G
    Munch Med Wochenschr; 1972 Jun; 114(22):1066-7. PubMed ID: 5068022
    [No Abstract]   [Full Text] [Related]  

  • 37. Amantadine in Parkinson's disease: pro and contra.
    Greulich W; Fenger E
    J Neural Transm Suppl; 1995; 46():415-21. PubMed ID: 8821077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Experimental and clinical data on the mechanism of action of amantadine and on its effectiveness in Parkinson's disease].
    Beani L; Bianchi C; Gomirato G; Perfetti C; Cartei M
    Minerva Med; 1971 Oct; 62(82):3948-51. PubMed ID: 5125048
    [No Abstract]   [Full Text] [Related]  

  • 39. Combined treatment in Parkinson's disease.
    Wheatley D
    Practitioner; 1983 Mar; 227(1377):446-7. PubMed ID: 6889232
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of the Parkinson syndrome with amantadine].
    Hartmann-von Monakow K
    Schweiz Med Wochenschr; 1971 Dec; 101(48):1736-9. PubMed ID: 5140093
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.